## Abstract A parkinsonian patient with severe outletβtype constipation was treated with injection of botulinum toxin into the puborectalis muscle. A total of 30 units (Botox) was injected in two sites. Resting anal pressure, maximum voluntary contraction, and pressure on straining were evaluated b
β¦ LIBER β¦
Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment
β Scribed by F. CADEDDU; A. R. BENTIVOGLIO; F. BRANDARA; G. MARNIGA; G. BRISINDA; G. MARIA
- Book ID
- 108604277
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 106 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Severe constipation in parkinson's disea
β
Dr. Alberto Albanese; Giorgio Maria; Anna Rita Bentivoglio; Giuseppe Brisinda; E
π
Article
π
1997
π
John Wiley and Sons
π
English
β 444 KB
BOTULINUM TOXIN TYPE A IN THE TREATMENT
β
Ailton Melo; Bernardo Rodrigues; Ana Caline NΓ³brega
π
Article
π
2009
π
John Wiley and Sons
π
English
β 38 KB
BOTULINUM TOXIN TYPE A IN THE TREATMENT
β
Andrea Santamato; Giancarlo Ianieri; Maurizio Ranieri; Marisa Megna; Francesco P
π
Article
π
2008
π
John Wiley and Sons
π
English
β 69 KB
Treatment of drooling in Parkinson's dis
β
Wolfgang H. Jost
π
Article
π
1999
π
John Wiley and Sons
π
English
β 87 KB
π 2 views
Botulinum toxin in the treatment of outl
β
Giorgio Maria; Giuseppe Brisinda; Anna Rita Bentivoglio; Emanuele Cassetta; Albe
π
Article
π
2000
π
Springer
π
English
β 655 KB
Cisapride treatment of constipation in p
β
Dr. W. H. Jost; K. Schimrigk
π
Article
π
1993
π
John Wiley and Sons
π
English
β 645 KB
## Abstract Constipation, a frequent symptom in Parkinson's disease (PD), is probably caused by degeneration of the autonomic nervous system, particularly the myenteric plexus. Cisapride is a drug that causes increased release of acetylcholine in the myenteric plexus. In a pilot study, cisapride th